FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200569369> ?p ?o ?g. }

• W4200569369 endingPage "422" @default.
• W4200569369 startingPage "412" @default.
• W4200569369 abstract "Immune checkpoint inhibitors (ICIs) are the standard treatment for advanced lung cancer, but immune-related adverse events (irAEs) remain poorly understood, especially in a real-world setting.A multicenter observational study was conducted. Medical records of lung cancer patients treated with ICIs at 26 hospitals from January 1, 2015, to February 28, 2021, were retrieved. Types of ICIs included antiprogrammed cell death 1 or antiprogrammed cell death ligand 1 (PD-L1) monotherapy, anticytotoxic T-lymphocyte antigen-4 monotherapy, or combination therapy.In total, 1905 patients with advanced lung cancer were evaluated. The median age was 63 (range 28-87) years, and the male/female ratio was 3.1:1 (1442/463). The primary histological subtype was adenocarcinoma (915). A total of 26.9% (512/1905) of the patients developed 671 irAEs, and 5.8% (110/1905) developed 120 grade 3-5 irAEs. Median duration from ICI initiation to irAEs onset was 56 (range 0-1160) days. The most common irAEs were thyroid dysfunction (7.2%, 138/1905), pneumonitis (6.5%, 124/1905), and dermatological toxicities (6.0%, 115/1905). A total of 162 irAEs were treated with steroids and 11 irAEs led to death. Patients with positive PD-L1 expression (≥1%) and who received first-line ICI treatment developed more irAEs. Patients who developed irAEs had a better disease control rate (DCR, 71.3% [365/512] vs. 56.0% [780/1145]; p < 0.001).The incidence rate of irAEs was 26.9% in a real-world setting. IrAEs might be related to a better DCR, but clinicians should be more aware of irAE recognition and management in clinical practice." @default.
• W4200569369 created "2021-12-31" @default.
• W4200569369 creator A5003642180 @default.
• W4200569369 creator A5003708121 @default.
• W4200569369 creator A5005546219 @default.
• W4200569369 creator A5008179879 @default.
• W4200569369 creator A5016385629 @default.
• W4200569369 creator A5017174775 @default.
• W4200569369 creator A5020202211 @default.
• W4200569369 creator A5022042647 @default.
• W4200569369 creator A5027271573 @default.
• W4200569369 creator A5030192491 @default.
• W4200569369 creator A5032939936 @default.
• W4200569369 creator A5033704922 @default.
• W4200569369 creator A5035492954 @default.
• W4200569369 creator A5040267650 @default.
• W4200569369 creator A5043365458 @default.
• W4200569369 creator A5055507868 @default.
• W4200569369 creator A5057117256 @default.
• W4200569369 creator A5064887006 @default.
• W4200569369 creator A5065277236 @default.
• W4200569369 creator A5065380119 @default.
• W4200569369 creator A5067350477 @default.
• W4200569369 creator A5068920157 @default.
• W4200569369 creator A5070256668 @default.
• W4200569369 creator A5071734705 @default.
• W4200569369 creator A5075407431 @default.
• W4200569369 creator A5077791798 @default.
• W4200569369 creator A5077990905 @default.
• W4200569369 creator A5079073938 @default.
• W4200569369 creator A5082941373 @default.
• W4200569369 creator A5084000653 @default.
• W4200569369 creator A5087149945 @default.
• W4200569369 creator A5089852487 @default.
• W4200569369 creator A5090482004 @default.
• W4200569369 date "2021-12-21" @default.
• W4200569369 modified "2023-10-17" @default.
• W4200569369 title "Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in <scp>China</scp>" @default.
• W4200569369 cites W2019607817 @default.
• W4200569369 cites W2096322385 @default.
• W4200569369 cites W2527905628 @default.
• W4200569369 cites W2560367415 @default.
• W4200569369 cites W2753065806 @default.
• W4200569369 cites W2762554941 @default.
• W4200569369 cites W2762777471 @default.
• W4200569369 cites W2768429453 @default.
• W4200569369 cites W2770404972 @default.
• W4200569369 cites W2783137027 @default.
• W4200569369 cites W2786816161 @default.
• W4200569369 cites W2796582438 @default.
• W4200569369 cites W2804191059 @default.
• W4200569369 cites W2805354595 @default.
• W4200569369 cites W2809615201 @default.
• W4200569369 cites W2884761157 @default.
• W4200569369 cites W2891486030 @default.
• W4200569369 cites W2891948100 @default.
• W4200569369 cites W2892640821 @default.
• W4200569369 cites W2896274372 @default.
• W4200569369 cites W2905314444 @default.
• W4200569369 cites W2908684819 @default.
• W4200569369 cites W2910245285 @default.
• W4200569369 cites W2912725678 @default.
• W4200569369 cites W2913035147 @default.
• W4200569369 cites W2915650040 @default.
• W4200569369 cites W2937826446 @default.
• W4200569369 cites W2945674342 @default.
• W4200569369 cites W2967398918 @default.
• W4200569369 cites W2972829090 @default.
• W4200569369 cites W2979129241 @default.
• W4200569369 cites W2996733487 @default.
• W4200569369 cites W3000357185 @default.
• W4200569369 cites W3009099064 @default.
• W4200569369 cites W3037506839 @default.
• W4200569369 cites W3095154565 @default.
• W4200569369 cites W3173405280 @default.
• W4200569369 cites W3209412516 @default.
• W4200569369 cites W4200569369 @default.
• W4200569369 doi "https://doi.org/10.1111/1759-7714.14274" @default.
• W4200569369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34935288" @default.
• W4200569369 hasPublicationYear "2021" @default.
• W4200569369 type Work @default.
• W4200569369 citedByCount "16" @default.
• W4200569369 countsByYear W42005693692021 @default.
• W4200569369 countsByYear W42005693692022 @default.
• W4200569369 countsByYear W42005693692023 @default.
• W4200569369 crossrefType "journal-article" @default.
• W4200569369 hasAuthorship W4200569369A5003642180 @default.
• W4200569369 hasAuthorship W4200569369A5003708121 @default.
• W4200569369 hasAuthorship W4200569369A5005546219 @default.
• W4200569369 hasAuthorship W4200569369A5008179879 @default.
• W4200569369 hasAuthorship W4200569369A5016385629 @default.
• W4200569369 hasAuthorship W4200569369A5017174775 @default.
• W4200569369 hasAuthorship W4200569369A5020202211 @default.
• W4200569369 hasAuthorship W4200569369A5022042647 @default.
• W4200569369 hasAuthorship W4200569369A5027271573 @default.
• W4200569369 hasAuthorship W4200569369A5030192491 @default.
• W4200569369 hasAuthorship W4200569369A5032939936 @default.
• W4200569369 hasAuthorship W4200569369A5033704922 @default.

• next